Assessment of trachoma in suspected endemic areas within 16 provinces in mainland China.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
01 2019
Historique:
received: 02 05 2018
accepted: 04 01 2019
revised: 07 02 2019
pubmed: 29 1 2019
medline: 24 4 2019
entrez: 29 1 2019
Statut: epublish

Résumé

China used to be among the countries with a high prevalence of trachoma. At the launch of The Global Elimination of Trachoma (GET) 2020 campaign by the World Health Organization (WHO) in 1996, China was placed on the list of countries endemic for trachoma based on historical data. However, empirical observation and routinely collected eye care data were suggesting that trachoma was no longer a public health problem. To determine whether the GET 2020 goals had been met in P. R. China, we conducted a targeted assessment with national scope. Province assessment teams, trained in WHO Trachoma Rapid Assessment (TRA) methodology and in WHO simplified trachoma grading system, carried out assessments in 16 provinces (among them, 2 provinces conducted pilot assessment). Based on the published literature, including national and international reports, suspected trachoma-endemic areas within each province were identified. Within these areas, trachomatous inflammation- follicular (TF) assessments were carried out in at least 50 grade-one children in primary schools serving villages with the lowest socio-economic development. Trachomatous trichiasis (TT) and corneal opacity (CO) assessments were conducted among persons aged 15 and over in villages within the catchment area of the selected schools. Of 8,259 children examined in 128 primary schools in 97 suspected trachoma endemic areas, only 16 cases of conjunctivitis were graded as TF. 38 cases with TT were found among the 339,013 examined residents in villages surrounding the schools. Among these 97 suspected trachoma endemic areas in only three was the prevalence of TT more than 0.2%. This large study suggested that trachoma was not a public health problem in 16 provinces that had been previously suspected to be endemic. These findings will facilitate planning for elimination of trachoma from PR China.

Sections du résumé

BACKGROUND
China used to be among the countries with a high prevalence of trachoma. At the launch of The Global Elimination of Trachoma (GET) 2020 campaign by the World Health Organization (WHO) in 1996, China was placed on the list of countries endemic for trachoma based on historical data. However, empirical observation and routinely collected eye care data were suggesting that trachoma was no longer a public health problem. To determine whether the GET 2020 goals had been met in P. R. China, we conducted a targeted assessment with national scope.
METHODOLOGY/PRINCIPAL FINDING
Province assessment teams, trained in WHO Trachoma Rapid Assessment (TRA) methodology and in WHO simplified trachoma grading system, carried out assessments in 16 provinces (among them, 2 provinces conducted pilot assessment). Based on the published literature, including national and international reports, suspected trachoma-endemic areas within each province were identified. Within these areas, trachomatous inflammation- follicular (TF) assessments were carried out in at least 50 grade-one children in primary schools serving villages with the lowest socio-economic development. Trachomatous trichiasis (TT) and corneal opacity (CO) assessments were conducted among persons aged 15 and over in villages within the catchment area of the selected schools. Of 8,259 children examined in 128 primary schools in 97 suspected trachoma endemic areas, only 16 cases of conjunctivitis were graded as TF. 38 cases with TT were found among the 339,013 examined residents in villages surrounding the schools. Among these 97 suspected trachoma endemic areas in only three was the prevalence of TT more than 0.2%.
CONCLUSIONS/SIGNIFICANCE
This large study suggested that trachoma was not a public health problem in 16 provinces that had been previously suspected to be endemic. These findings will facilitate planning for elimination of trachoma from PR China.

Identifiants

pubmed: 30689647
doi: 10.1371/journal.pntd.0007130
pii: PNTD-D-18-00439
pmc: PMC6366720
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0007130

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet Infect Dis. 2005 Dec;5(12):735-6
pubmed: 16310142
Ophthalmology. 2010 Mar;117(3):409-16, 416.e1
pubmed: 20079923
Br J Ophthalmol. 2010 Nov;94(11):1437-42
pubmed: 20852316
Zhonghua Yan Ke Za Zhi. 2012 Mar;48(3):199-204
pubmed: 22800416
Ophthalmology. 2013 Nov;120(11):2176-83
pubmed: 23714323
Bull World Health Organ. 1987;65(4):477-83
pubmed: 3500800

Auteurs

Jialiang Zhao (J)

Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Silvio Paolo Mariotti (SP)

Non Communicable Diseases and Mental Health, World Health Organization, Geneva, Switzerland.

Serge Resnikoff (S)

Brien Holden Vision Institute and SOVS, University of New South Wales, Sydney, Australia.

Yuqin Wang (Y)

Pharmacy Department, Xuanwu Hospital of Capital Medical University, Beijing, China.

Shicheng Yu (S)

Health Statistics Department, Chinese Center for Disease Control and Prevention, Beijing, China.

Mingguang He (M)

Centre for Eye Research Australia, University of Melbourne, Melbourne, Australia.

Yingchuan Fan (Y)

Department of Ophthalmology, Sichuan Provincial People's Hospital, Chengdu, China.

Haidong Zou (H)

Department of Ophthalmology, Shanghai First People's Hospital, Shanghai Jiaotong University, Shanghai, China.

Wenfang Zhang (W)

Department of Ophthalmology, The Second Hospital of Lanzhou University, Lanzhou, China.

Yading Jia (Y)

Department of Ophthalmology, Shanxi Eye Hospital, Taiyuan, China.

Lihua Wang (L)

Department of Ophthalmology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.

Huaijin Guan (H)

Eye Institute, Affiliated Hospital of Nantong University, Nantong, China.

Xiao Xu (X)

Rehabilitation Administration Department, National Institute of Hospital Administration, National Health and Family Planning Commission, Beijing, China.

Leilei Zhan (L)

Rehabilitation Administration Department, National Institute of Hospital Administration, National Health and Family Planning Commission, Beijing, China.

Lei An (L)

Rehabilitation Administration Department, National Institute of Hospital Administration, National Health and Family Planning Commission, Beijing, China.

Quanfu Ye (Q)

Rehabilitation Administration Department, National Institute of Hospital Administration, National Health and Family Planning Commission, Beijing, China.

Ningli Wang (N)

Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH